2014
DOI: 10.4161/hv.36162
|View full text |Cite
|
Sign up to set email alerts
|

Seroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
8
0
3

Year Published

2015
2015
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(13 citation statements)
references
References 26 publications
0
8
0
3
Order By: Relevance
“…In fact, this Tfh cell defect could contribute to the impaired vaccine responses reported in HIV infected individuals. For example, it has been shown that the immune response to both Hepatitis A and B vaccines seems to be reduced in HIV infected subjects (34). In addition, the levels of antibodies to tetanus toxoid and measles are significantly lower in HIV infected individuals (35), and (36).…”
Section: Discussionmentioning
confidence: 99%
“…In fact, this Tfh cell defect could contribute to the impaired vaccine responses reported in HIV infected individuals. For example, it has been shown that the immune response to both Hepatitis A and B vaccines seems to be reduced in HIV infected subjects (34). In addition, the levels of antibodies to tetanus toxoid and measles are significantly lower in HIV infected individuals (35), and (36).…”
Section: Discussionmentioning
confidence: 99%
“…It is also possible that doctors and parents may tend not to immunize HIV positive children to avoid complications from vaccination. 20 However complications are limited to replicating live attenuated vaccines and are quite rare. [21][22][23] Nevertheless, misconceptions about immunization of HIV-infected children among parents may hinder vaccination of HIV seropositive children.…”
Section: Discussionmentioning
confidence: 99%
“…Так, показники охоплення вакцинаці-єю становили 84,6 %, а достатні рівні антитоксичного імунітету мали 43,6 % осіб. І вже тут уперше було сфор-мульовано припущення, що, незважаючи на задовільну первинну відповідь на імунізацію, в подальшому втраті імунологічної пам'яті можна запобігти додатковими стратегіями збільшення дози вакцин [39]. Aktual'naâ Infektologiâ, ISSN 2312-413X (print), ISSN 2312-4148 (online)…”
unclassified